# Mehran Michael Bahrami, M.D. – FDA Inspection, Apr 19, 2024

Source: https://www.keypedia.com/records/fda_inspections/mehran-michael-bahrami-md/c0f4f772-9f5c-4031-8fad-f6bde783c1c6
Source feed: FDA_Inspections

> FDA inspection 1237334 of Mehran Michael Bahrami, M.D., April 19, 2024. Classification: Official Action Indicated (OAI). 4 citations under 21 CFR part 312.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1237334
- Company Name: Mehran Michael Bahrami, M.D.
- Inspection Date: 2024-04-19
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 4

## Related Officers

- [Company Rep](https://www.keypedia.com/people/ana-p-barido/4af1fa64-245e-4470-bd4b-975681d10a77)
- [Issuing Officer](https://www.keypedia.com/people/chantae-d-mitchell/0da68244-86f3-4119-b965-0b2dceb1c523)

Company: https://www.keypedia.com/companies/mehran-michael-bahrami-md/433e8447-9f6d-46e2-b72e-4b3051dbe610

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
